LRMR · Categories · Form 4

LRMR - SEC Form 4 insider transactions

Larimar Therapeutics Inc. (LRMR) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for LRMR

• 93d
  Chief Development Officer Shankar Gopi was granted 25,637 shares, increasing direct ownership by 50% to 76,443 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 93d
  Chief Medical Officer Clayton Russell was granted 25,637 shares, increasing direct ownership by 56% to 71,443 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 93d
  President and CEO Ben-Maimon Carole was granted 100,100 shares, increasing direct ownership by 37% to 368,276 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 93d
  Chief Financial Officer Celano Michael was granted 37,604 shares, increasing direct ownership by 21% to 215,785 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 350d
  SEC Form 4 filed by * Director by Deputization Flynn James E

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 351d
  SEC Form 4 filed by Director Sherman Jeffrey W

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 351d
  SEC Form 4 filed by Director Truitt Joseph

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 351d
  SEC Form 4 filed by Director Hamilton Thomas Edward

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 351d
  SEC Form 4 filed by Director Thomas Frank E

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 351d
  SEC Form 4 filed by Director Leff Jonathan S

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 461d
  Chief Development Officer Shankar Gopi was granted 23,306 shares, increasing direct ownership by 85% to 50,806 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 461d
  Chief Medical Officer Clayton Russell was granted 23,306 shares, increasing direct ownership by 104% to 45,806 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 461d
  President and CEO Ben-Maimon Carole was granted 91,000 shares, increasing direct ownership by 31% to 387,208 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 461d
  Chief Financial Officer Celano Michael was granted 34,185 shares, increasing direct ownership by 24% to 178,181 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 696d
  SEC Form 4 filed by Flynn James E

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 699d
  SEC Form 4 filed by Thomas Frank E

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 699d
  SEC Form 4 filed by Leff Jonathan S

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 699d
  SEC Form 4 filed by Sherman Jeffrey W

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 699d
  SEC Form 4 filed by Truitt Joseph

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 832d
  Shankar Gopi was granted 22,500 shares, increasing direct ownership by 450% to 27,500 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 832d
  Celano Michael was granted 31,250 shares, increasing direct ownership by 28% to 143,996 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 832d
  Clayton Russell was granted 22,500 shares (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 832d
  Ben-Maimon Carole was granted 66,125 shares, increasing direct ownership by 25% to 332,954 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 938d
  SEC Form 4 filed by Sherman Jeffrey W

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1017d
  SEC Form 4 filed by Clayton Russell

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1078d
  SEC Form 4 filed by Celano Michael

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1078d
  SEC Form 4 filed by Ben-Maimon Carole

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1078d
  SEC Form 4 filed by Truitt Joseph

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1085d
  SEC Form 4 filed by Flynn James E

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1085d
  SEC Form 4 filed by Truitt Joseph

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1085d
  SEC Form 4 filed by Hamilton Thomas Edward

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1085d
  SEC Form 4 filed by Leff Jonathan S

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1085d
  SEC Form 4 filed by Thomas Frank E

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1176d
  SEC Form 4 filed by Shankar Gopi

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1183d
  SEC Form 4: Celano Michael was granted 76,000 shares, increasing direct ownership by 239% to 107,746 units

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1183d
  SEC Form 4: Ben-Maimon Carole was granted 205,000 shares, increasing direct ownership by 361% to 261,829 units

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1318d
  SEC Form 4: Flynn James E bought $34,999,990 worth of shares (11,111,108 units at $3.15)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1318d
  SEC Form 4: Hamilton Thomas Edward bought $999,999 worth of shares (317,460 units at $3.15), increasing direct ownership by 167% to 507,590 units

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1319d
  SEC Form 4: Celano Michael bought $100,000 worth of shares (31,746 units at $3.15)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1319d
  SEC Form 4: Ben-Maimon Carole bought $100,000 worth of shares (31,746 units at $3.15), increasing direct ownership by 127% to 56,829 units

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1449d
  SEC Form 4 filed by Ben-Maimon Carole

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1449d
  SEC Form 4 filed by Celano Michael

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1449d
  SEC Form 4 filed by Truitt Joseph

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1449d
  SEC Form 4 filed by Barrett Peter

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1449d
  SEC Form 4 filed by Hamilton Thomas Edward

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1449d
  SEC Form 4 filed by Thomas Frank E

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1449d
  SEC Form 4 filed by Leff Jonathan S

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1450d
  SEC Form 4 filed by Flynn James E

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1561d
  SEC Form 4 filed by Celano Michael

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1561d
  SEC Form 4 filed by Ben-Maimon Carole

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1763d
  SEC Form 4: Flynn James E bought $5,999,962 worth of Common Stock (685,710 units at $8.75)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1763d
  SEC Form 4: Hamilton Thomas Edward bought $496,212 worth of Common Stock (56,710 units at $8.75), increasing direct ownership by 43% to 190,130 units

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1809d
  SEC Form 4 filed by Flynn James E

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1809d
  SEC Form 4 filed by LEFF JONATHAN S

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1809d
  SEC Form 4 filed by Daniel Thomas O

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1809d
  SEC Form 4 filed by Barrett Peter

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1809d
  SEC Form 4 filed by THOMAS FRANK E

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1925d
  SEC Form 4 filed by Carole Ben-Maimon

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1925d
  SEC Form 4 filed by Michael Celano

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)

Other LRMR categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends